Severity of COVID-19 at elevated exposure to perfluorinated alkylates.

Philippe GrandjeanClara Amalie Gade TimmermannMarie KruseFlemming NielsenPernille Just VinholtLasse BodingCarsten HeilmannKåre Mølbak

Published in: PloS one (2020)

Measures of individual exposures to immunotoxic PFASs included short-chain PFBA known to accumulate in the lungs. Elevated plasma-PFBA concentrations were associated with an increased risk of a more severe course of COVID-19. Given the low background exposure levels in this study, the role of exposure to PFASs in COVID-19 needs to be ascertained in populations with elevated exposures.

Keyphrases

coronavirus disease
sars cov
air pollution
respiratory syndrome coronavirus
early onset
drug induced